Northlane Capital Partners Invests in United States Drug Testing Laboratories
January 13, 2025
Northlane Capital Partners has acquired United States Drug Testing Laboratories (USDTL), a Des Plaines, Illinois-based forensic toxicology laboratory, in a transaction in which NCP invested alongside USDTL's management and founders Veronica and Doug Lewis. NCP will partner with management to expand USDTL's niche forensic testing capabilities and has appointed Albert Berger as CEO to lead the company's next phase of growth.
- Buyers
- Northlane Capital Partners
- Targets
- United States Drug Testing Laboratories Inc. (USDTL)
- Sellers
- Veronica Lewis, Doug Lewis, USDTL management team
- Industry
- Healthcare Services
- Location
- Illinois, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.